Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results
Mark D. Tyson(Vanderbilt University Medical Center), Daniel A. Barocas(Vanderbilt University Medical Center), Ralph Conwill(Vanderbilt-Ingram Cancer Center), David F. Penson(Geriatric Research Education and Clinical Center), Vivien W. Chen(Louisiana State University Health Sciences Center New Orleans), Mia Hashibe(University of California, Los Angeles), Tatsuki Koyama(Vanderbilt University Medical Center), Dan McCollum(Vanderbilt-Ingram Cancer Center), Sheldon Greenfield(University of California, Irvine), Lisa E. Paddock(Rutgers, The State University of New Jersey), Matthew R. Cooperberg(University of California, San Francisco), Ann S. Hamilton(University of Southern California), Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Xiao‐Cheng Wu(Louisiana State University Health Sciences Center New Orleans), Matthew J. Resnick(Vanderbilt University Medical Center), Antoinette M. Stroup(Rutgers, The State University of New Jersey), Dan Lee(Vanderbilt University Medical Center), Michael Goodman(Emory University)
Cited by 37
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688